Data Repository for Cancer Research
(iCaRe2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to gather data and biological samples from cancer patients, individuals at risk of developing cancer, and healthy individuals. The goal is to study cancer risk factors and develop new methods for prevention, detection, and treatment. Various hospitals and cancer centers, particularly in smaller and rural areas, collaborate in this effort. This trial suits those who have had cancer, are at risk for cancer, or are healthy and willing to contribute as controls. Participants must be able to consent and communicate in English or Spanish. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to significant advancements in cancer prevention and treatment.
Why are researchers excited about this trial?
Researchers are excited about the Integrated Cancer Repository for Cancer Research trial because it aims to revolutionize how we study cancer by creating a comprehensive database that integrates genetic, clinical, and treatment data from cancer patients. Unlike current methods that often rely on fragmented data, this approach provides a holistic view, potentially uncovering new insights into cancer progression and treatment responses. By enabling researchers to analyze vast amounts of data in an integrated manner, this trial could lead to more personalized and effective cancer therapies, ultimately improving outcomes for patients.
Who Is on the Research Team?
Quan Ly, MD
Principal Investigator
University of Nebraska
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Collection and banking of blood, DNA, and urine samples for future analysis
Registry Development
Development and implementation of a web-based Cancer Collaborative Registry
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nebraska
Lead Sponsor